6th International Conference of FACO 1
October 18 (Thu) 10:40-12:10 Room 4 (304, 3F, Conference Center)
- Chairs
-
Masahiko Nishiyama Department of Molecular Pharmacology and Oncology,
Graduate School of Medicine, Gunma University, Japan -
Jin Li Oncology Department, Shanghai East Hospital, China
- Theme
- Part 1: Ongoing Collaborative Study
- FACO
1-1 - International retrospective cohort study on conversion therapy for stage IV gastric cancer (CONVO-GC) 1, the first clinical trial of FACO
- Department of Surgical Oncology, Graduate School of Medicine, Gifu University, Japan
- Kazuhiro Yoshida
- FACO
1-2 - Recent state of the treatment of stage IV gastric cancer in China
- Division of Clinical Medicine, Department of Medical Oncology,
Sun Yat-sen University Cancer Center, China - Miao-Zhen Qiu
- FACO
1-3 - Recent state of the treatment of stage IV gastric cancer in Korea: Precision medicine with multi-arms trial in gastric cancer
- Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Korea / Medical Oncology, Yonsei Cancer Center, Korea / Songdang Institute for Cancer Research, Korea
- Sun Young Rha
- FACO
1-4 - Update on international retrospective cohort study of locoregional and systemic therapy in oligometastatic breast cancer (OLIGO-BC1)
- Department of Breast Surgery, Kyorin University Hospital, Japan
- Shigeru Imoto
- FACO
1-5 - Update on the treatment of advanced HER2-positive breast cancer
- Breast Cancer, Department of Oncology,
The First Affiliated Hospital of Nanjing Medical University, China - Yongmei Yin
- FACO
1-6 - Update reports on breast cancer—Precision medicine in breast cancer
- Oncology / Hematology, Internal Medicine, Korea University, Korea
- Kyong Hwa Park
6th International Conference of FACO 2
October 18 （Thu） 16:50-17:50 Room 4 (304, 3F, Conference Center)
- Chairs
-
Masahiko Nishiyama Department of Molecular Pharmacology and Oncology,
Graduate School of Medicine, Gunma University, Japan -
Taeyou Kim Center for Precision Medicine, Division of Medical Oncology,
Seoul National University Hospital, Korea
- Theme
- Part 2: Future Study
- FACO
2-1 - The progress of pancreatic cancer in 2018: New idea and new concept
- Pancreatic Surgery, Fudan University Shanghai Cancer Center, China ／
Shanghai Pancreatic Cancer Institution, China ／
Fudan University Pancreatic Cancer Institution, China - Xianjun Yu
- FACO
2-2 - Treatment strategy for locally advanced pancreatic cancer—From the viewpoint of surgeon from Korea—
- Division of HBP, Department of Surgery, University of Yonsei, Korea
- Dong-Sup Yoon
- FACO
2-3 - Cohort study of patients with initially unresectable pancreatic cancer in whom conversion surgery is planned after FOLFIRINOX or gemcitabine plus nab-paclitaxel therapy (PC-CURE-1)
- Department of Medical Oncology, Faculty of Medicine, Kyorin University, Japan
- Junji Furuse
- FACO
2-4 - Hepatoblastoma present and future—Current status of international clinical research on hepatoblastoma
- Division of Life Science, Natural Science Center for
Basic Research and Development, Hiroshima University, Japan ／
Department of Pediatric Surgery, Hiroshima University Hospital, Japan - Eiso Hiyama
6th International Conference of FACO 3
October 20 （Sat） 8:30-10:30 Room 4 (304, 3F, Conference Center)
- Chairs
-
Jun Zhu Lymphoma Department, Peking University Cancer Hospital, Peking University, China -
Shingo Yano Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Japan
- Theme
- Part 3: Lymphoma Research Advances
- FACO
3-1 - Current status of clinical research in lymphoma from China
- Lymphoma Department, Medical Oncology, Peking University Cancer Hospital, China
- Yuqin Song
- FACO
3-2 - Current status of translational research in lymphoma from China
- Shanghai Institute of Hematology, China
- Weili Zhao
- FACO
3-3 - Lymphoma research advances: Current status from Korea
- Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Korea ／
Seoul National University Cancer Research Institute, Korea - Tae Min Kim
- FACO
3-4 - Lymphoma research advances: Current status from Japan
- Hematology, International University of Health and Welfare Mita Hospital, Japan
- Yukio Kobayashi
More programs are available at the 56th Annual Meeting of Japan Society of Clinical Oncology, which will be held in conjunction with the 6th International Conference of FACO.
